NUAK2 and glioblastoma: Patients in the top 25% for NUAK2 (GBM-NUAK2high) expression were compared to those in the bottom 25% for NUAK2 (GBM-NUAK2low) expression to obtain patient DEGs (Dataset EV1-2).